The role of Enterococcus faecalis in alcoholic liver disease
粪肠球菌在酒精性肝病中的作用
基本信息
- 批准号:10046278
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-10-01 至 2022-09-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAlcohol abuseAlcohol dependenceAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholismAlcoholsBacteriophagesBindingBiological ModelsBone MarrowCellsCessation of lifeChronicDataDevelopmentDiseaseEndotoxinsEnterococcus faecalisEthanolEtiologyExperimental ModelsFecesFunctional disorderGnotobioticHealthHepaticHepatocyteHepatotoxicityInflammationInflammatoryInterleukin-1 ReceptorsInterleukin-1 betaInterventionIntestinal MucosaIntestinal permeabilityIntestinesKupffer CellsLaboratoriesLeadLeaky GutLipopolysaccharidesLiverLiver CirrhosisLiver diseasesLyticMediatingMedicalModelingMolecularMorbidity - disease rateMucous MembraneMusMyelogenousNatural regenerationNaturePathogenesisPatientsPlayPre-Clinical ModelProteinsPublicationsResearchRoleSamplingSurfaceTLR2 geneTestingTransgenic OrganismsTranslatingUnited StatesVeteransVirulence Factorsanakinraantimicrobialbasechronic alcohol ingestioncytokinedefined contributiondysbiosisfeedinggut bacteriagut colonizationgut microbiotagut-liver axishumanized mouseinnovationinsightisletliver inflammationliver injurymicrobialmicrobiomemicrobiome researchmicrobiotamortalitymouse modelnovelnovel strategiespathogenpreventproblem drinkerreceptorresponse
项目摘要
Alcohol abuse and alcohol-related diseases are a major cause of morbidity and mortality among Veterans.
Chronic alcoholism is associated with changes in the intestinal microbiota, increased intestinal permeability,
and elevated systemic levels of bacterial products. How chronic alcohol use results in intestinal dysbiosis and
whether specific bacterial species mediate alcoholic liver disease is not known. Results from our laboratory
indicate that Enterococcus faecalis (E faecalis) is sufficient to cause mild steatotic liver disease and to
exacerbate alcoholic liver disease in mice. Most importantly, we observed significantly greater numbers of E
faecalis in fecal samples from alcohol-dependent patients with or without liver disease than healthy controls.
Our preliminary data further shows that alcohol-mediated suppression of the antimicrobial protein regenerating
islet derived-3 (REG3G) allows E faecalis colonization of intestinal mucosal surfaces and translocation to the
liver. E faecalis induces liver inflammation via binding to pathogen recognition receptors on Kupffer cells. A
subsequent increase in expression and secretion of the inflammatory cytokine interleukin (IL)-1β contributes to
the development of ethanol-induced liver disease. This is supported by our findings that chimeric mice lacking
toll-like receptor (TLR)-2 on bone-marrow derived cells have reduced E faecalis-exacerbated alcoholic liver
disease. The focus of this application is to characterize the role of E faecalis in preclinical models of alcoholic
liver disease and Veterans with alcohol abuse. We hypothesize that E faecalis is an important etiological factor
in the modulation of hepatic inflammation and the development of alcoholic liver disease. Our experimental
approach is to use mouse models of chronic alcohol feeding to investigate the role of alcohol-induced
suppression of intestinal REG3G. Lower intestinal REG3G facilitates overgrowth of E faecalis on mucosal
surfaces in the intestine and translocation to the liver (Aim 1). We will investigate the molecular mechanism of
how translocation of E faecalis contributes to hepatic inflammation and hepatocyte death during alcoholic liver
disease (Aim 2). Using a precision-microbiome approach, we will test the hypothesis that targeted manipulation
of alcohol-associated dysbiosis can ameliorate alcoholic liver disease (Aim 3). We believe these studies will
provide novel insights into the contribution of the microbiota to alcoholic liver disease. Innovative and novel
strategies will be developed to prevent or ameliorate alcoholic liver disease in Veterans.
酗酒和酒精相关疾病是退伍军人发病和死亡的主要原因。
慢性酒精中毒与肠道微生物群的变化、肠道通透性增加、
以及细菌产物的全身水平升高。长期饮酒如何导致肠道菌群失调和
我们实验室的结果尚不清楚特定细菌种类是否介导酒精性肝病。
表明粪肠球菌(E faecalis)足以引起轻度脂肪肝病并
最重要的是,我们观察到小鼠中酒精性肝病的数量显着增加。
患有或不患有肝病的酒精依赖患者的粪便样本中的粪肠球菌含量高于健康对照。
我们的初步数据进一步表明,酒精介导的抗菌蛋白再生抑制
胰岛衍生-3 (REG3G) 允许粪肠球菌在肠粘膜表面定植并易位至
粪肠球菌通过与库普弗细胞 A 上的病原体识别受体结合诱导肝脏炎症。
随后炎症细胞因子白细胞介素 (IL)-1β 的表达和分泌增加有助于
我们发现嵌合小鼠缺乏乙醇诱导的肝病。
骨髓来源细胞上的 Toll 样受体 (TLR)-2 可减少粪肠球菌加剧的酒精肝
该应用的重点是表征粪肠球菌在酒精临床前模型中的作用。
我们发现,肝病和退伍军人酗酒是一个重要的病因。
在我们的实验中,肝脏炎症的调节和酒精性肝病的发展。
方法是使用慢性酒精喂养的小鼠模型来研究酒精诱导的作用
肠道 REG3G 的抑制促进粘膜上粪肠球菌的过度生长。
肠道表面并易位至肝脏(目标 1)。
粪肠球菌易位如何导致酒精肝期间的肝脏炎症和肝细胞死亡
疾病(目标 2),我们将使用精确微生物组方法来检验靶向操纵的假设。
酒精相关的生态失调可以改善酒精性肝病(目标 3)。
为微生物群对酒精性肝病的贡献提供新颖的见解。
将制定预防或改善退伍军人酒精性肝病的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernd G. Schnabl其他文献
Bernd G. Schnabl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernd G. Schnabl', 18)}}的其他基金
The role of Enterococcus faecalis in alcoholic liver disease
粪肠球菌在酒精性肝病中的作用
- 批准号:
10292950 - 财政年份:2018
- 资助金额:
-- - 项目类别:
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
肠道菌群在酒精性肝病中的作用
- 批准号:
9900694 - 财政年份:2017
- 资助金额:
-- - 项目类别:
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
肠道菌群在酒精性肝病中的作用
- 批准号:
10296622 - 财政年份:2017
- 资助金额:
-- - 项目类别:
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
肠道菌群在酒精性肝病中的作用
- 批准号:
10652248 - 财政年份:2017
- 资助金额:
-- - 项目类别:
相似国自然基金
年龄与异质对酗酒影响的建模与分析
- 批准号:11861044
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
酗酒相关问题的建模及研究
- 批准号:11461041
- 批准年份:2014
- 资助金额:36.0 万元
- 项目类别:地区科学基金项目
酗酒者易患肺部感染及高致死率的发病机制研究
- 批准号:U1404814
- 批准年份:2014
- 资助金额:30.0 万元
- 项目类别:联合基金项目
与酗酒毒害性相关的细胞色素CYP2E1蛋白酶催化反应机理及动力学的理论研究
- 批准号:21273095
- 批准年份:2012
- 资助金额:78.0 万元
- 项目类别:面上项目
酗酒促发外伤性蛛网膜下腔出血的生物力学机制及其量化法医病理学鉴定的研究
- 批准号:30772458
- 批准年份:2007
- 资助金额:28.0 万元
- 项目类别:面上项目
相似海外基金
A genetically informative approach to understanding the impact of spousal psychiatric disorders on alcohol use disorder onset, remission, and relapse
一种了解配偶精神疾病对酒精使用障碍发作、缓解和复发影响的遗传信息方法
- 批准号:
10718384 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Substance use treatment and county incarceration: Reducing inequities in substance use treatment need, availability, use, and outcomes
药物滥用治疗和县监禁:减少药物滥用治疗需求、可用性、使用和结果方面的不平等
- 批准号:
10585508 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Using patient-level decision modeling to improve use of treatments for alcohol use disorder
使用患者层面的决策模型来改善酒精使用障碍治疗的使用
- 批准号:
10712474 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Biochemical Studies Underlying Acute Ethanol's Antidepressant-like effects during Withdrawal in a Preclinical Model of Ethanol Dependence
乙醇依赖临床前模型中戒断期间乙醇急性抗抑郁样作用的生化研究
- 批准号:
10595193 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Optimization of Drug-like Properties of CRFBP-CRF2 Negative Allosteric Modulators for Alcohol Use Disorder
CRFBP-CRF2 负变构调节剂治疗酒精使用障碍的类药特性优化
- 批准号:
10804469 - 财政年份:2023
- 资助金额:
-- - 项目类别: